Necrotizing Soft Tissue Infections of the Upper Extremity.

Hand Clin · Aug 2020 · Review

Melillo A, Addagatla K, Jarrett NJ

Division of Plastic Surgery, Cooper University Health Care, 3 Cooper Plaza

Hand & Upper Extremity

SUMMARY — THE REDUCTIONThis review outlines risk factors, diagnosis, and treatment of upper extremity necrotizing soft tissue infections, emphasizing that prompt surgical debridement and antimicrobial therapy are critical given high amputation and mortality rates.
Abstract, as published

Necrotizing soft tissue infections of the upper extremity have varying microbiologies and etiologies. Risk factors for development include diabetes mellitus, intravenous drug use, peripheral arterial disease, smoking, alcohol abuse, and immunocompromised state. Although clinical examination is the mainstay of diagnosis, laboratory tests and imaging can aid in diagnosis. Surgical débridements usually are needed for treatment, with resultant defects that often require reconstruction. Rates of amputation are reported as 22% to 37.5% and mortality from necrotizing soft tissue infections of the upper extremity from 22% to 34%. Prompt surgical and antimicrobial treatment is necessary to decrease risk of loss of limb or life.

Featured in the 2026-08-29 issue.

← Economic Impact of Hand and Wrist Injuries: Health-Care Costs…Revision Thumb Carpometacarpal Arthroplasty. →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.